ABBVIE INC.

ABBV
Delayed Quote. Delayed  - 05/27 04:03:14 pm
150USD -0.38%

Turn to zoom
Prev.150.0000
Open149.5200
High150.0500
Low147.7500
Volume8 403 429
Latest news
8h ago
8h ago
8h ago
1d ago
Chart ABBVIE INC.
Technical analysis trends
Short TermMid-TermLong Term
TrendNeutralNeutralBullish
Resistance162175175
Spread/Res.-8,6%-15%-15%
Spread/Supp.0,97%29%9,1%
Support147115136
Financials
Sales 2022 59 604 M - -
Net income 2022 17 475 M - -
Net Debt 2022 53 760 M - -
P/E ratio 2022 15,6x
Yield 2022 3,79%
Capitalization 266 B 266 B -
EV / Sales 2022 5,37x
EV / Sales 2023 5,52x
Nbr of Employees 50 000
Free-Float 99,9%
Company
AbbVie Inc. specializes in therapeutic drug research and development. Its products are intended for treating rheumatoid arthritis, psoriasis, Crohnâ'Ts disease, thyroid disease, Parkinsonâ'Ts disease, HIV, complications of mucoviscidosis, low testosterone levels, and complications associated with...

>> Read more
Sector :
Other Pharmaceuticals
Calendar :
2022-06-01 Presentation
Trading Rating :
Investor Rating :

Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 25
Last Close Price 150,57 $
Average target price 164,23 $
Spread / Average Target 9,07%